Mark B. McClellan, MD, PhD, MPA | Markle
Mark B. McClellan, MD, PhD, MPA | Markle

Mark B. McClellan, MD, PhD, MPA

Senior Fellow and Director, Engelberg Center for Health Care Reform

Leonard D. Schaeffer Chair in Health Policy Studies, The Brookings Institution

A doctor and economist by training, Mark B. McClellan, MD, PhD, MPA, is a Senior Fellow and Director of the Engelberg Center for Health Care Reform, and Leonard D. Schaeffer Chair in Health Policy Studies at the Brookings Institution. He is also a former administrator for the Centers for Medicare & Medicaid Services (CMS) and former commissioner of the Food and Drug Administration (FDA). While at CMS and FDA, he developed and implemented major reforms in health policy, including the Medicare prescription drug benefit, the FDA’s Critical Path Initiative, and public-private initiatives to develop better information on the quality and cost of care.

McClellan’s professional experience includes: associate professor of economics and of medicine, Stanford University, 1995-present; administrator, Centers for Medicare & Medicaid Services, 2004-2006; commissioner of Food and Drugs, 2002-2004; member, President’s Council of Economic Advisers and senior director for Health Care, White House, 2001-2002; member, Institute of Medicine, 2003-present; research associate, National Bureau of Economic Research, 1995- 2001, 2006-present; national fellow, Hoover Institution, Stanford University, 2000-2001; director, Program on Health Outcomes Research, Stanford Medical School, 1999-2001; associate editor, Journal of Health Economics, 1998-2001; and deputy assistant secretary for Economic Policy, US Department of the Treasury, 1998-1999.

McClellan holds a PhD in economics from the Massachusetts Institute of Technology, an MD from Harvard University-Massachusetts Institute of Technology Division of Health Sciences and Technology, an MPA from Harvard University and a BA from the University of Texas at Austin.